Sponsored Link:

Page Analysis

Sponsored Link:

valortim.fr


http://www.valortim.fr/
698 ratings.1163 user reviews.

Web page information

  1. Keywords hit in search results
    ® ability administered affinity against announced announces annual anthracis anthrax antibody antigen approved augment bacteria biodefense biological capsaicin ceflatonin chemical ciprofloxacin company concentration concomitantly countermeasures designed destroy developing development diseases dosing drugs emerging evaluate exposure fully further generation homoharringtonine human humans immune include infection medical meeting monoclonal orphan pharmathene phemce present presented presents prevention product program programs progress prophylactic protective protexia purpose rbche recombinant research safety second short sparvax sparvax& sparvax™ stakeholders status study system target therapeutic threats today tolerability topical toxin trade treatment vaccine valortim valortim® which workshop
  2. Search Engine Recommended Keywords
    Anthrax Toxins, Anthrax Antitoxin,
PharmAthene | Valortim® Anthrax Anti-Toxin
Valortim® Anthrax Anti-Toxin. VALORTIM ® – POST-EXPOSURE PROPHYLACTIC and THERAPEUTIC ANTHRAX ANTI-TOXIN MONOCLONAL ANTIBODY (MAb)
http://www.pharmathene.com/product-portfolio/valortim-anthrax-anti-toxin
valortim.com
http://valortim.com/
valortim.org
http://valortim.org/
Ph1 Study of Valortim and Ciprofloxacin in Humans - Full Text View ...
The purpose of this study is to evaluate the safety and tolerability of short-term dosing of IV ciprofloxacin when administered concomitantly with IV Valortim in ...
http://clinicaltrials.gov/ct2/show/NCT00964561
Data Show Valortim Anthrax Anti-Toxin May Augment Immune System's ...
New Valortim(R) Data Presented at the 8th Annual ASM Biodefense and Emerging Diseases Research Meeting PharmAthene, Inc. (NYSE Amex PIP), a biodefense company d
http://www.drugs.com/clinical_trials/data-show-valortim-anthrax-anti-toxin-may-augment-immune-s-ability-destroy-anthrax-bacteria-8903.html
New FDA Orphan Drugs: Ceflatonin, Valortim, TQ-1018
: The FDA has approved orphan drug status for homoharringtonine (Ceflatonin), MDX-1303 (Valortim), and a high-concentration topical capsaicin product (TQ-1018).
http://www.medscape.com/viewarticle/528927
Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System ...
Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria. New Valortim(R) Data Presented at the 8th Annual ASM ...
http://www.prnewswire.com/news-releases/data-show-valortimr-anthrax-anti-toxin-may-augment-immune-systems-ability-to-destroy-anthrax-bacteria-85189772.html
PharmAthene to Present Data for rPA Anthrax Vaccine, Protexia(R ...
PharmAthene to Present Data for rPA Anthrax Vaccine, Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2009.
http://www.prnewswire.com/news-releases/pharmathene-to-present-data-for-rpa-anthrax-vaccine-protexiar-and-valortimr-at-hhs-phemce-stakeholders-workshop-2009-78217687.html
PharmAthene Presents Data for Valortim Anthrax Anti-Toxin and ...
PharmAthene, Inc. (NYSE Amex PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data fr
http://www.drugs.com/clinical_trials/pharmathene-presents-data-valortim-anthrax-anti-toxin-third-generation-rpa-anthrax-vaccine-programs-7993.html
Ph1 Study of Valortim and Ciprofloxacin in Humans
Valortim (MDX-1303) is a fully human monoclonal antibody (hmAb) with a high affinity for B. anthracis protective antigen (PA). Valortim is designed to target PA, which is ...
http://www.bioportfolio.com/resources/trial/73449/Ph1-Study-Of-Valortim-And-Ciprofloxacin-In-Humans.html

News Results

PharmAthene Announces Further Progress In Development Of Its SparVax(TM) Anthrax Vaccine Program
PharmAthene's lead product development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection ...
Marketwatch
PharmAthene Announces Further Progress In Development Of Its SparVax™ Anthrax Vaccine Program
PharmAthene's lead product development programs include: SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection rBChE - a ...
ad-hoc-news.de
PharmAthene Announces Further Progress In Development Of Its SparVax™ Anthrax Vaccine Program
PharmAthene's lead product development programs include: SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection ...
Yahoo Finance
No Coupons found for this website.

500 characters left

Your Review: (5 out of 5)
refresh captcha


Server Information
IP Address: 0.0.0.0
Site Disclaimer:

All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. PageGlimpse.com is not responsible for any incorrect or incomplete information. PageGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.